Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Dabigatran versus Warfarin in Patients with Atrial Fibrillation2009 · 11,216 citations
2. 2Milvexian, an orally bioavailable, small‐molecule, reversible, direct inhibitor of factor XIa: In vitro studies and in vivo evaluation in experimental thrombosis in rabbits2021 · 61 citations
3. 3Edoxaban versus Warfarin in Patients with Atrial Fibrillation2013 · 5,142 citations
4. 4Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation2011 · 9,422 citations
5. 5Atrial fibrillation in patients with ischemic stroke: A population-based study2009 · 56 citations